Identifying which regulatory agency will give approval for a new product may be more confusing than expected for many companies developing genetically modified organisms. In the case of the British company, Oxitec, that recently developed a genetically modified mosquito to combat dengue virus, obtaining approval in the United States resulted in unnecessary delay due to confusion over which regulatory branch is responsible for providing approval for this type of product.

read more: Biotech Regulatory News: Genetically Modified Animals